Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2020/06/026173
CTRI/2020/06/026173CompletedPhase 3

A Pre-clinical and Clinical study to Evaluate the Efficacy of Arjuna Ksheerapaka Churna in the Management of Medoroga w.s.r. to Dyslipidemia

RGGPG Ayurvedic College1 site in 1 country30 target enrollmentStarted: January 7, 2020Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Fulfillment of objective and subjective criteria
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

I would like to publish my research trial after its completion as soon as possible. A total of 30 subjects will be studied in two groups: reference control group and trial group. The outcome will be analysed based on subjective and objective parameters with appropriate statistical tools.

Study Design

Study Type
Interventional
Allocation
Random Number Table
Masking
Open Label

Eligibility Criteria

Ages
20.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •a) Diagnosed and confirmed cases of dyslipidemia on the basis of investigations.
  • •b) Patient between the age group of 20-70 years of either sex who will fulfill the criteria of diagnosis.

Exclusion Criteria

  • •a) Patient not willing for the trial.
  • •b) Patients suffering from major systemic illness necessitating long term treatment (R.A., PTB, malignancy).
  • •c) Poorly controlled hypertensive patients (SBP ≥ 140 mm of Hg and/or DSB ≥ 90 mm of Hg).
  • •d) Patient having past history of MI and unstable angina.
  • •e) Patients having concomitant disorders like ischemic heart disease, congestive heart failure, acute renal failure, chronic renal failure etc.
  • •f) Patients below 20 years and above 70 years of age.
  • •g) Patients who are participating in any other clinical trial or have completed participation during the past three months.
  • •h) Any condition which the investigator thinks may compromise with the safety of the subject.

Outcomes

Primary Outcomes

Fulfillment of objective and subjective criteria

Time Frame: 56 days

Secondary Outcomes

  • Control of Lipid Profile(8 weeks)

Investigators

Sponsor
RGGPG Ayurvedic College
Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
To study the efficacy ofAshwagandhadi Avaleha as an Adjuvant with Anti Tubercular Treatment.
CTRI/2021/05/033863Principal60
Not yet recruiting
Not Applicable
Efficacy of Neelkanthi churna in Madhumeha w.s.r to Type 2 Diabetes Mellitus
CTRI/2021/06/034030Principal30
Not yet recruiting
Phase 2
A study to determine the efficacy of amritadya guggulu and haritaki churna in medo roga
CTRI/2023/11/059698Prof Anjana Mishra30
Not yet recruiting
Phase 1/2
"To evaluate the efficacy of Madhuyashti Granules and Shirodhara in the management of Attention Deficit Hyperactivity Disorder (ADHD) in school going children."
CTRI/2023/04/052151RGGPG Ayurvedic College40
Not yet recruiting
Not Applicable
A comparative study between phaltrikadi Kashaya & phaltrikadi Kashaya Ghana vati in the management of non alcoholic fatty liver disease
CTRI/2023/08/056191Rajiv Gandhi Govt Post Graduate Ayurvedic College and hospital Paprola50